Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners
Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...
Hosted on MSN2d
Clarity jumps as FDA awards fast track status for PET scan imaging agent
Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the ...